Pediatric Patient Ages, TRF Lengths, and Telomerase Activities
| Patient No. . | Pediatric Patients . | ||
|---|---|---|---|
| Time After Birth (mo) . | TRF Length (kb) . | Telomerase Activity . | |
| Patient 1 | 0.0 | 7.40 | − |
| 1.0 | 10.04 | − | |
| 4.0 | 9.57 | + | |
| 6.0 | 9.22 | − | |
| 9.0 | 9.15 | − | |
| 12.0 | 8.52 | − | |
| 18.0 | 8.66 | − | |
| 24.0 | 8.68 | − | |
| Patient 2 | 0.0 | 11.54 | − |
| 1.0 | 10.95 | − | |
| 6.0 | 11.22 | + | |
| 9.0 | 10.05 | − | |
| 12.0 | 11.02 | − | |
| 15.0 | 11.18 | − | |
| 24.0 | 10.54 | − | |
| 36.0 | 10.80 | − | |
| Patient 3 | 0.7 | 9.81 | − |
| 3.0 | 10.28 | − | |
| 6.0 | 9.94 | − | |
| 9.0 | 10.30 | − | |
| 17.0 | 9.77 | − | |
| 24.0 | 9.55 | ND | |
| Patient 4 | 0.0 | 8.09 | ++ |
| 0.3 | 9.88 | + | |
| 1.5 | 10.02 | + | |
| 3.0 | 10.80 | + | |
| 6.0 | 10.32 | + | |
| 9.0 | 10.48 | + | |
| 12.0 | 10.73 | + | |
| 18.0 | 10.31 | + | |
| 24.0 | 9.89 | − | |
| 36.0 | 9.15 | + | |
| Patient 5 | 1.0 | 10.98 | − |
| 2.0 | 11.05 | − | |
| 5.0 | 10.92 | − | |
| 12.0 | 10.73 | − | |
| 16.0 | 10.35 | − | |
| 27.0 | 10.50 | − | |
| Patient 6 | 1.0 | 9.89 | + |
| 6.0 | 9.68 | ++ | |
| 12.0 | 9.57 | + | |
| 24.0 | 9.62 | − | |
| 37.0 | 9.18 | ++ | |
| Patient 7 | 0.5 | 10.63 | ++ |
| 2.0 | 10.93 | + | |
| 3.0 | 10.39 | + | |
| 6.0 | 10.11 | − | |
| 9.0 | 10.67 | − | |
| Patient 8 | 1.0 | 11.30 | + |
| 6.0 | 10.90 | + | |
| 9.0 | 11.25 | − | |
| 36.0 | 11.24 | − | |
| Patient 9 | 0.0 | 11.04 | + |
| 2.0 | 11.07 | − | |
| 8.0 | 10.71 | − | |
| 12.0 | 10.75 | − | |
| 18.0 | 10.85 | − | |
| 26.0 | 10.78 | − | |
| Patient No. . | Pediatric Patients . | ||
|---|---|---|---|
| Time After Birth (mo) . | TRF Length (kb) . | Telomerase Activity . | |
| Patient 1 | 0.0 | 7.40 | − |
| 1.0 | 10.04 | − | |
| 4.0 | 9.57 | + | |
| 6.0 | 9.22 | − | |
| 9.0 | 9.15 | − | |
| 12.0 | 8.52 | − | |
| 18.0 | 8.66 | − | |
| 24.0 | 8.68 | − | |
| Patient 2 | 0.0 | 11.54 | − |
| 1.0 | 10.95 | − | |
| 6.0 | 11.22 | + | |
| 9.0 | 10.05 | − | |
| 12.0 | 11.02 | − | |
| 15.0 | 11.18 | − | |
| 24.0 | 10.54 | − | |
| 36.0 | 10.80 | − | |
| Patient 3 | 0.7 | 9.81 | − |
| 3.0 | 10.28 | − | |
| 6.0 | 9.94 | − | |
| 9.0 | 10.30 | − | |
| 17.0 | 9.77 | − | |
| 24.0 | 9.55 | ND | |
| Patient 4 | 0.0 | 8.09 | ++ |
| 0.3 | 9.88 | + | |
| 1.5 | 10.02 | + | |
| 3.0 | 10.80 | + | |
| 6.0 | 10.32 | + | |
| 9.0 | 10.48 | + | |
| 12.0 | 10.73 | + | |
| 18.0 | 10.31 | + | |
| 24.0 | 9.89 | − | |
| 36.0 | 9.15 | + | |
| Patient 5 | 1.0 | 10.98 | − |
| 2.0 | 11.05 | − | |
| 5.0 | 10.92 | − | |
| 12.0 | 10.73 | − | |
| 16.0 | 10.35 | − | |
| 27.0 | 10.50 | − | |
| Patient 6 | 1.0 | 9.89 | + |
| 6.0 | 9.68 | ++ | |
| 12.0 | 9.57 | + | |
| 24.0 | 9.62 | − | |
| 37.0 | 9.18 | ++ | |
| Patient 7 | 0.5 | 10.63 | ++ |
| 2.0 | 10.93 | + | |
| 3.0 | 10.39 | + | |
| 6.0 | 10.11 | − | |
| 9.0 | 10.67 | − | |
| Patient 8 | 1.0 | 11.30 | + |
| 6.0 | 10.90 | + | |
| 9.0 | 11.25 | − | |
| 36.0 | 11.24 | − | |
| Patient 9 | 0.0 | 11.04 | + |
| 2.0 | 11.07 | − | |
| 8.0 | 10.71 | − | |
| 12.0 | 10.75 | − | |
| 18.0 | 10.85 | − | |
| 26.0 | 10.78 | − | |
Shown are the data obtained from all nine of our pediatric patients, including the time the samples were obtained after birth, the measured TRF length, and whether telomerase activity was detected in the sample.
Abbreviation: ND, not determined.